GlycoVaxyn AG Appoints Renowned Vaccinologist Dr Stanley Plotkin to Supervisory Board

October 6, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

SCHLIEREN, Switzerland--(BUSINESS WIRE)--GlycoVaxyn, a pioneer in the development of innovative conjugated vaccines, announced today that the world renowned vaccinologist Dr Stanley A Plotkin has been elected to its Supervisory Board.

Twitter
LinkedIn
Facebook
Email
Print

People Europe